News
Public · Published
Cardinal Health Is Maintained at Overweight by Morgan Stanley
Morgan Stanley maintained its Overweight rating on Cardinal Health and raised its price target to $286.00 per share from $265.00.
Published:
Updated:
What happened
Morgan Stanley maintained its Overweight rating on Cardinal Health and raised its price target to $286.00 per share from $265.00.
Confirmed
Global impact / market context
An Overweight rating means the analyst expects the stock to do better than the average stock they cover. A higher price target shows the analyst sees more room for the share price to rise, which can draw investor attention to Cardinal Health.
Analyst inference
Ratings from large banks like Morgan Stanley are widely followed because they signal how professional analysts view a company's prospects. The move raises the expected value of the shares in the eyes of that analyst, without any reported change to Cardinal Health's actual business results.
Analyst inference
What to watch
- Whether Morgan Stanley keeps its Overweight rating on Cardinal Health or changes it later. Confirmed
- Watch for other research firms to update their own ratings or price targets for Cardinal Health after this move. Proposed
- Any later company news on sales, costs, or profit could shift whether analysts keep or lower their targets. Analyst inference
Evidence
- Original source link unavailable